Not checked for notices yet.

Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study

Giancarlo Comi, Stuart Cook, Kottil Rammohan and 5 more (opens in a new tab)

Therapeutic Advances in Neurological Disorders · 2018

doi:10.1177/1756285617753365 (opens in a new tab)

Cited by papers we hold 1

Immunological Aspects of Approved MS Therapeutics · 2019
No notice

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.